No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase IV
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
Contrast Media / administration & dosage*
-
Contrast Media / adverse effects
-
Drug Administration Schedule
-
Gadolinium DTPA / administration & dosage*
-
Gadolinium DTPA / adverse effects
-
Glatiramer Acetate
-
Humans
-
Interferon beta-1b
-
Interferon-beta / therapeutic use
-
Magnetic Resonance Imaging*
-
Multiple Sclerosis / drug therapy
-
Multiple Sclerosis / pathology*
-
Peptides / therapeutic use
-
Safety
Substances
-
Adjuvants, Immunologic
-
Contrast Media
-
Peptides
-
Interferon beta-1b
-
Glatiramer Acetate
-
Interferon-beta
-
Gadolinium DTPA